What is taboo investing?
“Taboo” is a young word in English. It arrives in 1777, borrowed from the Polynesian tapu, and it didn't mean shameful or dirty. It meant something closer to sacred: consecrated, set apart, too charged to be handled. The forbidden and the profound, held in a single word. Somewhere between that meaning and ours we lost the second half, and with it the sense that these are the places a culture stores its real voltage.
Why do taboo categories get underfunded?
Notice what the word never meant: wrong. Charged is not the same as immoral. Capital flows freely into categories with well-documented harm and flinches from the ones that merely make people squirm, so the taboo label attaches to discomfort, not harm. That's a labelling error, and labelling errors are where value hides.
Taboo moves first
Taboo never holds still. There is an Overton window of taboo, and it is constantly shifting: what is unspeakable in one decade is unremarkable the next. Because it sits at the very edge of what a culture will say out loud, a shift there is the earliest visible sign of a larger one coming, the leading edge of a mega-trend before it has a name. Death cafes. Menopause clinics on the high street. Recovery discussed openly in boardrooms. In 2023 The Economist declared menopause had “gone mainstream.” The conversations surfacing now are the tell.
Why invest now?
Venture has a rhythm: cultural acceptance always precedes capital acceptance, sometimes by a decade, and the returns are made in the lag. The founders climbing the slope now aren't chasing novelty; they're building clinical, data-driven, IP-rich businesses on the last frontier we've left, the body. Not indulgence, but infrastructure, and because they own their science, their edge compounds rather than commoditising.
Why Tabu Ventures
Knowing the gap exists isn't the same as being able to act on it. We're early-mover investors built for exactly this: a syndicate that sources the founders, a network of operators who can judge what's genuinely investable, and the discipline to move while a category is still uncomfortable rather than waiting for it to be obvious. We buy the slope, not the peak.
Where we focus
We concentrate on four categories where the science is real and the stigma is fading:
Sexual wellness
A lifelong human need, funded like an embarrassment.
Explore →Women's health
Half the population, roughly 5% of the research.
Explore →Addiction & recovery
A proven market serious builders still avoid.
Explore →Death & end of life
Universal, enormous, and almost entirely unbuilt.
Explore →